Extendicare Inc. (TSE:EXE – Free Report) – Investment analysts at Leede Financial raised their FY2025 earnings per share estimates for Extendicare in a report released on Wednesday, November 13th. Leede Financial analyst D. Loe now expects that the company will post earnings of $1.29 per share for the year, up from their previous forecast of $0.90. The consensus estimate for Extendicare’s current full-year earnings is $0.61 per share. Leede Financial also issued estimates for Extendicare’s FY2026 earnings at $1.39 EPS.
Other equities analysts have also issued research reports about the stock. Royal Bank of Canada raised their price objective on shares of Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th. TD Securities lifted their price target on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a “hold” rating in a research report on Thursday, November 14th.
Extendicare Price Performance
The company has a fifty day moving average price of C$9.27 and a two-hundred day moving average price of C$8.16. Extendicare has a twelve month low of C$6.45 and a twelve month high of C$10.43. The firm has a market capitalization of C$862.25 million, a price-to-earnings ratio of 15.19 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a quick ratio of 0.98 and a current ratio of 0.60.
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which was paid on Friday, November 15th. Shareholders of record on Thursday, October 31st were paid a dividend of $0.04 per share. This represents a $0.48 dividend on an annualized basis and a yield of ∞. The ex-dividend date of this dividend was Thursday, October 31st. Extendicare’s dividend payout ratio is presently 70.59%.
About Extendicare
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Investing in the High PE Growth Stocks
- Applied Materials Market Capitulates: Now is the Time to Buy
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
